Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
Researchers report lower than expected rates of genetic testing in a study of women with breast and ovarian cancer, MedPage Today reports.
A Florida bill would prevent insurance companies in the state from considering genetic data in life or long-term care coverage decisions, according to the Tampa Bay Times.
Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.
The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.
By partnering with telehealth provider PWNHealth, Lineagen wants to help children on the autism spectrum start treatment faster and qualify for more benefits.
The index fell more than 11 percent in December, underperforming the Dow and the Nasdaq, but performing on par with the Nasdaq Biotechnology Index.
The analysis found that charges for suspected genetic diseases account for between 11 percent and 46 percent of pediatric healthcare costs in the US.
Perceived genetic risk can affect individuals' physiology more than their actual genetic risk, raising questions about when to disclose such information.
A comprehensive study of genomics malpractice lawsuits showed only a modest increase in recent years, but ASU’s Marchant wouldn't bet on it staying this way in the long term.
The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.
Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.
Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.
In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.